I earned my MD and MPH from Tehran University of Medical Sciences in 2021 and conducted research on venous thromboembolism, atrial fibrillation, ischemic and valvular heart disease, and cardiovascular complications of systemic illnesses. I participated in the CANARY randomized trial of catheter-directed fibrinolysis for pulmonary embolism, published in JAMA Cardiology. I also collaborated with the Global Burden of Disease (GBD) project, contributing to influential Lancet and Nature Communications publications. Since May 2024, I have been a postdoctoral research fellow at the Thrombosis Research Group, Brigham and Women’s Hospital, Harvard Medical School. My work spans validation of pulmonary embolism detection algorithms, predictors of thrombotic events, and systematic reviews in cardiovascular care, with publications in the Journal of Thrombosis and Haemostasis, Critical Care, and others. I led a meta-analysis demonstrating the safety of oral anticoagulation alone vs. anticoagulation plus antiplatelet therapy in atrial fibrillation with stable coronary disease. I contributed to the HI-PRO randomized trial of extended low-dose apixaban, published in NEJM. My work has been presented at ISTH, AHA, and the Peer Review Congress. My goal is to advance as a physician-scientist in cardiovascular disease and thrombosis, integrating clinical expertise with research to improve cardiovascular care.